Quarterly report pursuant to Section 13 or 15(d)

Note 5 - Stockholders' Deficit

v3.10.0.1
Note 5 - Stockholders' Deficit
3 Months Ended
Sep. 30, 2018
Notes To Financial Statements [Abstract]  
Stockholders' Deficit

Advisory Agreements

 

Catalyst Global LLC. Effective April 1, 2018, we entered into a renewal contract (the “2018 Renewal”) with Catalyst Global LLC to provide investor relations services for 12 months in exchange for monthly fees of $4,500 per month and 34,840 shares of restricted common stock per quarter. During the three months ended September 30, 2018, we issued 8,710 shares of common stock valued at $2.01 per share or $17,507. The 2018 Renewal is cancelable upon 60 days written notice.  

 

Shenzhen Reach Investment Development Co. (“SRID”). On March 14, 2018, we entered into a consulting agreement with SRID to assist us with identifying strategic partners, suppliers and manufacturers in China for a term of 12 months. Included with the services is a two-week trip to China to meet with potential manufacturers, which took place in April 2018. In consideration for the services, we agreed to issue to SRID, up to 174,672 shares of restricted common stock valued at approximately $80,000 over the course of the 12-month term. As of September 30, 2018, 116,158 shares have been issued.

 

Warrant Activity

 

Warrant detail is reflected below:

 

    Number    

Weighted Average

Exercise Price Per

Share

   

Remaining Contract

Term (# years)

 
Shares purchasable under outstanding warrants at June 30, 2018     1,740,790     $ 2.03       0.74  
Stock purchase warrants exercised     (40,000 )   $ 2.00       -  
Shares purchasable under outstanding warrants at September 30, 2018     1,700,790     $ 2.03       0.47  

 

Stock-based Compensation 

 

On November 26, 2014, our board of directors approved our 2014 Equity Incentive Plan (the “2014 Plan”), which was approved by our shareholders on February 17, 2015. The 2014 Option Plan was amended by our board of directors on October 26, 2017 and approved by our shareholders on July 23, 2018. The 2014 Plan offers selected employees, directors, and consultants the opportunity to acquire our common stock, and serves to encourage such persons to remain employed by us and to attract new employees. The 2014 Plan allows for the award of stock and options, up to 10,000,000 shares of our common stock.

 

Activity in stock options during the three months ended September 30, 2018 and related balances outstanding as of that date are reflected below:

 

   

Number of

Shares

   

Weighted

Average

Exercise Price

   

Weighted

Average

Remaining

Contract

Term (# years)

 
Outstanding at June 30, 2018     3,544,473     $ 0.83       8.87  
Granted     335,264                  
Exercised     -                  
Forfeited and cancelled     103,125                  
Outstanding at September 30, 2018     3,766,612     $ 0.94       8.33  
Exercisable at September 30, 2018     1,609,667     $ 0.77       7.99  

 

Activity in stock options during the three months ended September 30, 2017 and related balances outstanding as of that date are reflected below:

 

   

Number of

Shares

   

Weighted

Average

Exercise Price

   

Weighted

Average

Remaining

Contract

Term (# years)

 
Outstanding at June 30, 2017     716,277     $ 1.01        
Granted     -                
Exercised     -                
Forfeited and cancelled     -                
Outstanding at September 30, 2017     716,277     $ 1.01       6.83  
Exercisable at September 30, 2017     612,623     $ 1.09       6.60  

 

Stock-based compensation expense recognized in our condensed consolidated statements of operations for the three months ended September 30, 2018 and 2017, includes compensation expense for stock-based options and awards granted based on the grant date fair value. For options and awards granted, expenses are amortized under the straight-line method over the expected vesting period. Stock-based compensation expense recognized in the condensed consolidated statements of operations has been reduced for estimated forfeitures of options that are subject to vesting. Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.

 

Our average stock price during the three months ended September 30, 2018 was $2.27 and as a result the intrinsic value of the exercisable options at September 30, 2018 was $2,218,000.

 

We allocated stock-based compensation expense included in the condensed consolidated statements of operations for employee option grants and non-employee option grants as follows:

 

Three months ended September 30,   2018     2017  
Research and development   $ 15,000     $ 8,000  
General and administrative     149,000       3,000  
Total stock-based compensation expense   $ 164,000     $ 11,000  

 

The Company uses the Black-Scholes valuation model to calculate the fair value of stock options. The fair value of stock options was measured at the grant date using the assumptions (annualized percentages) in the table below:

 

Three months ended September 30,   2018     2017  
Expected volatility     142 %     100 %
Risk free interest rate     2.63 %     1.31 %
Forfeiture rate     20.0 %     23.0 %
Dividend yield     0 %     0 %
Expected term (years)     5       3  

 

The remaining amount of unrecognized stock-based compensation expense at September 30, 2018 relating to outstanding stock options is approximately $1,648,000 which is expected to be recognized over the weighted average period of 1.47 years.